

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
German chemical giants Bayer AG and BASF SE are both considering takeovers of U.S. seed behemoth Monsanto, according to news reports on Thursday.
Of the potential Bayer takeover of Monsanto, valued at roughly $40 billion, Bloomberg noted that it "would create the world's largest supplier of seeds and farm chemicals."
As USA Today reported, "A bid for Monsanto would be just the most recent in a wave of chemical and agribusiness consolidation."
Indeed, in February China National Chemical Corp. (ChemChina) announced it would acquire Swiss pesticide company Syngenta for $43 billion, while DuPont and Dow Chemical announced their merger last year.
According to advocacy group Food & Water Watch, such consolidation has far-reaching impacts, and is bad news for farmers and communities.
"A Bayer takeover of Monsanto would only be the latest in a string of high-profile seed and agrochemical mergers that are undermining the economic viability of family farms," said Wenonah Hauter, the organization's executive director. "Unchecked food and agribusiness monopolies pay farmers less, charge consumers more and reduce everyone's choices."
"The Department of Justice must block deals like the proposed ChemChina-Syngenta and Dow-DuPont mergers that already threaten to hyper-consolidate the biotech seed industry," she argued. "Doing so would also send a message that mega-mergers like the rumored Bayer-Monsanto deal will not be rubber stamped.
"The shocking consolidation in the biotech seed and agrochemical industry turns over the food system to a cabal of chemical companies that would make it even harder for farmers, consumers and communities to build a vibrant, sustainable food system," Hauter said.
The potential merger, Bloomberg reports, "would face a global antitrust review." The paper also quotes Erik Gordon, a professor at University of Michigan's Ross School of Business, who said that it may be slowed down by regulators who "are faced not with a decision about a single deal, but rather with a decision about the structural concentration of the whole industry."
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
German chemical giants Bayer AG and BASF SE are both considering takeovers of U.S. seed behemoth Monsanto, according to news reports on Thursday.
Of the potential Bayer takeover of Monsanto, valued at roughly $40 billion, Bloomberg noted that it "would create the world's largest supplier of seeds and farm chemicals."
As USA Today reported, "A bid for Monsanto would be just the most recent in a wave of chemical and agribusiness consolidation."
Indeed, in February China National Chemical Corp. (ChemChina) announced it would acquire Swiss pesticide company Syngenta for $43 billion, while DuPont and Dow Chemical announced their merger last year.
According to advocacy group Food & Water Watch, such consolidation has far-reaching impacts, and is bad news for farmers and communities.
"A Bayer takeover of Monsanto would only be the latest in a string of high-profile seed and agrochemical mergers that are undermining the economic viability of family farms," said Wenonah Hauter, the organization's executive director. "Unchecked food and agribusiness monopolies pay farmers less, charge consumers more and reduce everyone's choices."
"The Department of Justice must block deals like the proposed ChemChina-Syngenta and Dow-DuPont mergers that already threaten to hyper-consolidate the biotech seed industry," she argued. "Doing so would also send a message that mega-mergers like the rumored Bayer-Monsanto deal will not be rubber stamped.
"The shocking consolidation in the biotech seed and agrochemical industry turns over the food system to a cabal of chemical companies that would make it even harder for farmers, consumers and communities to build a vibrant, sustainable food system," Hauter said.
The potential merger, Bloomberg reports, "would face a global antitrust review." The paper also quotes Erik Gordon, a professor at University of Michigan's Ross School of Business, who said that it may be slowed down by regulators who "are faced not with a decision about a single deal, but rather with a decision about the structural concentration of the whole industry."
German chemical giants Bayer AG and BASF SE are both considering takeovers of U.S. seed behemoth Monsanto, according to news reports on Thursday.
Of the potential Bayer takeover of Monsanto, valued at roughly $40 billion, Bloomberg noted that it "would create the world's largest supplier of seeds and farm chemicals."
As USA Today reported, "A bid for Monsanto would be just the most recent in a wave of chemical and agribusiness consolidation."
Indeed, in February China National Chemical Corp. (ChemChina) announced it would acquire Swiss pesticide company Syngenta for $43 billion, while DuPont and Dow Chemical announced their merger last year.
According to advocacy group Food & Water Watch, such consolidation has far-reaching impacts, and is bad news for farmers and communities.
"A Bayer takeover of Monsanto would only be the latest in a string of high-profile seed and agrochemical mergers that are undermining the economic viability of family farms," said Wenonah Hauter, the organization's executive director. "Unchecked food and agribusiness monopolies pay farmers less, charge consumers more and reduce everyone's choices."
"The Department of Justice must block deals like the proposed ChemChina-Syngenta and Dow-DuPont mergers that already threaten to hyper-consolidate the biotech seed industry," she argued. "Doing so would also send a message that mega-mergers like the rumored Bayer-Monsanto deal will not be rubber stamped.
"The shocking consolidation in the biotech seed and agrochemical industry turns over the food system to a cabal of chemical companies that would make it even harder for farmers, consumers and communities to build a vibrant, sustainable food system," Hauter said.
The potential merger, Bloomberg reports, "would face a global antitrust review." The paper also quotes Erik Gordon, a professor at University of Michigan's Ross School of Business, who said that it may be slowed down by regulators who "are faced not with a decision about a single deal, but rather with a decision about the structural concentration of the whole industry."